Item 2.02. Results of Operations and Financial Condition.
On
The preliminary selected financial results reported by the Company are
unaudited, subject to adjustment, and provided as an approximation in advance of
the Company's announcement of complete financial results in
The information contained in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing and except as expressly provided by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press Release ofKiniksa Pharmaceuticals, Ltd. , datedJanuary 9, 2023 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
© Edgar Online, source